Average Co-Inventor Count = 4.64
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kymera Therapeutics, Inc. (23 from 35 patents)
2. Novartis Ag (15 from 3,923 patents)
3. Mitobridge, Inc. (5 from 20 patents)
4. Orsobio, Inc. (2 from 6 patents)
5. Paq Therapeutics Inc. (1 from 1 patent)
46 patents:
1. 12516068 - Protein degraders and uses thereof
2. 12454520 - Protein degraders and uses thereof
3. 12404285 - KRAS G12D proteolysis targeting chimeras
4. 12378200 - Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors
5. 12258341 - IRAK degraders and uses thereof
6. 12168057 - IRAK degraders and uses thereof
7. 12150995 - IRAK degraders and uses thereof
8. 12077555 - STAT degraders and uses thereof
9. 12006329 - Protein degraders and uses thereof
10. 11993585 - Poly-ADP ribose polymerase (PARP) inhibitors
11. 11932635 - CRBN ligands and uses thereof
12. 11932624 - MDM2 degraders and uses thereof
13. 11897882 - Tricyclic crbn ligands and uses thereof
14. 11807636 - IRAK degraders and uses thereof
15. 11780812 - Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors